Tilray (NASDAQ:TLRY) is a licensed cannabis producer in Canada. The company is American-owned, but is based in Nanaimo, BC.

It sells cannabis and cannabis-related products domestically in Canada, as well as to countries in Europe, the South Pacific and Latin America.


After being a privately owned company for five years, Tilray was the first cannabis stock to launch on the NASDAQ on July 9, 2018. The stock offered to the public is Class 2 stock, which holds one vote per share; Class 1 stock on the other hand carries three votes per share.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Seventy-five million Class 1 shares are privately owned, making Tilray a “controlled company,” with the majority of its voting power privately controlled.

Tilray stock has skyrocketed from a starting price of US$17 after its IPO, and there are a number of factors that have caused the company’s exponential climb.

Those include a rumored deal with alcohol giant Diageo (LSE:DGE) — some believe Tilray is the frontrunner out of three candidates that have been earmarked as potential partners for the company. So far no other news has come out, but Tilray stock soared after this story broke out.

Another factor that has boosted Tilray stock is its Q2 2018 report, where it revealed a 95-percent increase in revenue year-over-year.

Some say Tilray stock will continue on its tear until October 17, 2018, the day cannabis is legalized in Canada. However, others believe the bubble will burst before that day comes, calling the company’s spike since its IPO unsustainable.

One cannabis analyst has suggested Tilray stock and other key players have been “hijacked by traders,” and has cautioned investors not to get caught up in the momentum. Time will tell for Tilray stock.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Amanda Kay, hold no direct investment interest in any company mentioned in this article. 

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less